Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) Study

NCT02061306 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02061306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02061306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) Study
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 31, 2014
Completion date
December 31, 2027
Enrollment
500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease